Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AILERON THERAPEUTICS INC | 16,609,449 | reported | 08 Jan 2021 | tx 8+12,878,106−1,438,611 |
| Annexon, Inc. | 10,342,134 | reported | 28 May 2026 | tx 21+11,112,631−15,461,390 |
| Whitehawk Therapeutics, Inc. | 21,400 | reported | 18 Jun 2019 | tx 35+3,542,800 |
| Akebia Therapeutics, Inc. | 12,500 | reported | 14 Jun 2018 | tx 21+3,079,542−785,894 |
| HeartWare LTD | 8,572 | reported | 13 Aug 2009 | tx 18+6,250,003.73 |
| Eledon Pharmaceuticals, Inc. | 0 | reported | 22 Sept 2014 | tx 6+1,771,688−16,979,131 |
| IMMUNIC, INC. | 0 | reported | 17 Sept 2018 | tx 32+11,362,962−17,522,679 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 9 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | PURCHASE | Annexon, Inc. | 613,497 | 5.41 USD | anomaly |
| 21 Nov 2025 | PURCHASE | Annexon, Inc. | 422,613 | 4.28 USD | anomaly |
| 20 Nov 2025 | PURCHASE | Annexon, Inc. | 400,000 | 4.48 USD | anomaly |
| 19 Nov 2025 | PURCHASE | Annexon, Inc. | 500,000 | 3.94 USD | anomaly |
| 17 Nov 2025 | PURCHASE | Annexon, Inc. | 500,000 | 2.99 USD | first after silenceanomaly |
| 18 Nov 2025 | PURCHASE | Annexon, Inc. | 500,000 | 3.18 USD | anomaly |
| 05 Jun 2025 | GRANT_AWARD | Annexon, Inc. | 55,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Annexon, Inc. | 44,000 | 0.00 USD | deriv |
| 26 Dec 2023 | PURCHASE | Annexon, Inc. | 350,000 | 2.88 USD | |
| 08 Jun 2023 | GRANT_AWARD | Annexon, Inc. | 24,000 | 0.00 USD | deriv |
| 10 Feb 2023 | PURCHASE | Annexon, Inc. | 2,647,058 | 6.80 USD | anomaly |
| 07 Jul 2022 | PURCHASE | Annexon, Inc. | 2,453,988 | 3.84 USD | anomaly |
| 07 Jul 2022 | PURCHASE | Annexon, Inc. | 613,497 | 0.13 USD | derivfirst after silence |
| 09 Jun 2022 | GRANT_AWARD | Annexon, Inc. | 24,000 | 0.00 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | Annexon, Inc. | 10,000 | 0.00 USD | deriv |
| 08 Jan 2021 | PURCHASE | AILERON THERAPEUTICS INC | 9,000,000 | 1.10 USD | anomaly |
| 28 Jul 2020 | PURCHASE | Annexon, Inc. | 200,000 | 17.00 USD | anomaly |
| 28 Jul 2020 | CONVERSION | Annexon, Inc. | 1,754,978 | — | |
| 28 Jul 2020 | CONVERSION | Annexon, Inc. | 3,095,238 | — | deriv |
| 28 Jul 2020 | CONVERSION | Annexon, Inc. | 4,016,573 | — | deriv |
| 28 Jul 2020 | CONVERSION | Annexon, Inc. | 5,537,036 | — | deriv |
| 28 Jul 2020 | CONVERSION | Annexon, Inc. | 2,812,543 | — | deriv |
| 08 Jun 2020 | PURCHASE | AILERON THERAPEUTICS INC | 3,700,000 | 1.10 USD | first after silenceanomaly |
| 18 Jun 2019 | GRANT_AWARD | Whitehawk Therapeutics, Inc. | 21,400 | 0.00 USD | deriv |
| 10 Jan 2019 | PURCHASE | Whitehawk Therapeutics, Inc. | 23,818 | 2.45 USD |
6 purchases reported after at least 12 months of silence — most recent on 17 Nov 2025.